Biotechnology doesn’t fall neatly into any one of the 16 government-designated critical infrastructure sectors that receive specialized and focused attention from feds, leading some lawmakers to worry that it’s not getting the protection from cyberattacks and other risks that it needs.
That’s why a bipartisan group of senators and representatives announced legislation Thursday that would place an emphasis at the Cybersecurity and Infrastructure Security Agency on defending biotechnology, biomanufacturing and biological data.
The Protecting Biotechnology and Biomanufacturing as Critical Infrastructure Act and the Protecting Biological Data Act are two separate bills with the same group of cosponsors. Both bills would weave biotech into the law that established the Department of Homeland Security.
The former would direct DHS to come up with plans to make sure biotech and biomanufacturing are protected as critical infrastructure, but not as a whole new sector. The plans would identify key biotech players, conduct outreach to them and develop steps to update the National Infrastructure Protection Plan this year to incorporate biotech sector input.
The latter would make sure that systems handling genomic sequences and sensitive biometric data are covered as critical infrastructure and integrated into the national cyber strategy, that CISA would work with biotech players on security steps like joint exercises and that the agency would get new personnel to handle biometric data security.
In the last two months, biotech giants Boston Scientific and Amgen have revealed that they suffered recent cyberattacks.
Sponsors of the measures include leaders and members of the National Security Commission on Emerging Biotechnology, a legislative advisory group.